NICE draft guidance refuses pembrolizumab plus axitinib combination
The National Institute for Health and Care Excellence (NICE) have issued [...]
New risk scoring system for metastatic kidney cancer
The treatment options for metastatic renal cell carcinoma (RCC) have [...]
Nephrectomy after complete response to immunotherapy
A retrospective study looked at the clinical and surgical outcomes [...]
Cancer vaccine could ‘boost’ immunotherapy effectiveness
A major new study has discovered a means to increase [...]
Atezolizumab and bevacizumab in patients with advanced non-clear cell renal cell carcinoma
Dr Rana McKay from University of California in San Diego, [...]
Selecting therapy for poor-risk advanced kidney cancer
In this video interview, Dr Earle Burgess from the Levine [...]
New study shows causes of previously unexplained cancers
An “unprecedented” study has revealed the most comprehensive map of [...]
Monitoring treatment toxicities in patients with renal cell carcinoma
Drs Dan George and Tian Zhang from the Duke Prostate [...]
Real-world clinical outcomes with first-line sunitinib for metastatic kidney cancer
A paper published in The Oncologist last month analysed real-world [...]
Prognosis of type 1 and type 2 papillary renal cell carcinoma
In a recent analysis of a large database, researchers compared [...]
